Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Resmed Inc shares valued at $2,056,076 were sold by Farrell Michael J. on Jul 07 ’25. At $256.72 per share, Farrell Michael J. sold 8,009 shares. The insider’s holdings dropped to 455,503 shares worth approximately $115.81 million following the completion of this transaction.
Also, Farrell Michael J. purchased 8,009 shares, netting a total of over 2,056,076 in proceeds.
Before that, FARRELL PETER C had sold 945 shares from its account. In a trade valued at $241,438, the Director traded Resmed Inc shares for $255.49 each. Upon closing the transaction, the insider’s holdings decreased to 945 shares, worth approximately $17.36 million.
As published in a research note from RBC Capital Mkts on July 15, 2025, Resmed Inc [RMD] has been rated up from a Sector perform to an Outperform and the price target has been revised to $294. Analysts at Morgan Stanley started covering the stock with ‘”an Overweight”‘ outlook in a report released in mid March. As of March 19, 2025, Morgan Stanley has initiated its “an Overweight” rating for RMD. Earlier on January 16, 2025, Goldman initiated its rating. Their recommendation was “a Buy” for RMD stock.
Analyzing RMD Stock Performance
On last trading session,, Resmed Inc [NYSE: RMD] rose 0.89% to $254.25. The stock’s lowest price that day was $250.18, but it reached a high of $254.45 in the same session. During the last five days, there has been a drop of approximately -0.68%. Over the course of the year, Resmed Inc shares have jumped approximately 24.13%. Shares of the company reached a 52-week high of $263.05 on 01/30/25 and a 52-week low of $199.92 on 04/07/25.
Support And Resistance Levels for Resmed Inc (RMD)
According to the 24-hour chart, there is a support level at 251.47, which, if violated, would cause prices to drop to 248.69. In the upper region, resistance lies at 255.74. The next price resistance is at 257.23. RSI (Relative Strength Index) is 52.48 on the 14-day chart, showing neutral technical sentiment.
Is Resmed Inc subject to short interest?
Stocks of Resmed Inc saw a sharp steep in short interest on 2025-06-13 dropping by -1.01 million shares to 9.93 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 10.93 million shares. A decline of -10.12% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 11.58 of the overall float, the days-to-cover ratio (short ratio) decline to 11.58.
Which companies own the most shares of Resmed Inc (RMD)?
In terms of Resmed Inc share price expectations, FactSet research, analysts set an average price target of 265 in the next 12 months, up nearly 5.15% from the previous closing price of $252.01. Analysts anticipate Resmed Inc stock to reach 286 by 2025, with the lowest price target being 240. In spite of this, 19 analysts ranked Resmed Inc stock as Buy at the end of 2025. On January 10, 2025, Piper Sandler assigned a price target of “a Neutral” to the stock and initiated coverage with a $252.
